Different techniques for ACT detection, different criteria for the selection of controls and AD patients or small numbers of cases and controls included in the studies may account for contradictory results regarding the association of abnormal ACT plasma levels with AD. The gene discussed is SERPINA3; the disease is Alzheimer disease.